Wyeth, Progenics drug flunks trial
This is a discussion on Wyeth, Progenics drug flunks trial within the Biotechnology News forum, part of the Industry News and Updates category; Wyeth and Progenics were handed a serious blow today when their intravenous drug methylnaltrexone for postoperative ileus flunked the first ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-12-2008, 01:40 PM
|
|||
|
|||
Wyeth, Progenics drug flunks trial
Wyeth and Progenics were handed a serious blow today when their intravenous drug methylnaltrexone for postoperative ileus flunked the first of two Phase III trials. Initial results from the study Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| SPOTLIGHT: Cancer drug flunks Phase III | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
| Wyeth, Progenics drug flunks Phase III trial | industry_news | Biotechnology News | 0 | 03-19-2008 09:08 AM |
© 2008 DrugManagementForum™ powered by |
 |